{"entity":{"type":"insider","cik":"0001568678","url":"/insider/0001568678","json_url":"/insider/0001568678.json","name":"Mattes Glenn R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2013-10-31","last":"2022-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Mattes Glenn R.","source":"filing","n_filings":10,"first_seen":"2013-10-31","last_seen":"2022-05-17"}],"transactions":[{"id":6614395,"accession":"0001213900-22-027791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-027791","line_url":"/filing/0001213900-22-027791#line-1","is_derivative":false,"issuer_cik":"0001568678","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001568678","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":76480.0,"total_display":"76,480.00","total_whole":"76,480","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider"},{"id":5438397,"accession":"0001213900-21-048369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-048369","line_url":"/filing/0001213900-21-048369#line-1","is_derivative":false,"issuer_cik":"0001568678","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001568678","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":71000.0,"total_display":"71,000.00","total_whole":"71,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-16","filed_date":"2021-09-16","scope":"insider"},{"id":4747733,"accession":"0001213900-21-016183","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-016183","line_url":"/filing/0001213900-21-016183#line-2","is_derivative":false,"issuer_cik":"0001568678","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001568678","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":17.04,"price_display":"17.04","price_state":"stated","total_value":852000.0,"total_display":"852,000.00","total_whole":"852,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":4850016,"accession":"0001213900-21-010415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-010415","line_url":"/filing/0001213900-21-010415#line-2","is_derivative":false,"issuer_cik":"0001568678","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001568678","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":16.82,"price_display":"16.82","price_state":"stated","total_value":672800.0,"total_display":"672,800.00","total_whole":"672,800","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":4437712,"accession":"0001213900-21-003298","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-003298","line_url":"/filing/0001213900-21-003298#line-3","is_derivative":false,"issuer_cik":"0001568678","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001568678","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":17.51,"price_display":"17.51","price_state":"stated","total_value":700400.0,"total_display":"700,400.00","total_whole":"700,400","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-20","scope":"insider"},{"id":2914515,"accession":"0001213900-20-045177","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-20-045177","line_url":"/filing/0001213900-20-045177#line-2","is_derivative":false,"issuer_cik":"0001568678","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001568678","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":15.33,"price_display":"15.33","price_state":"stated","total_value":459900.0,"total_display":"459,900.00","total_whole":"459,900","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-29","scope":"insider"},{"id":3326137,"accession":"0001213900-20-037057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-20-037057","line_url":"/filing/0001213900-20-037057#line-2","is_derivative":false,"issuer_cik":"0001568678","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001568678","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108830.0,"shares_display":"108,830","price_per_share":14.995,"price_display":"15.00","price_state":"stated","total_value":1631905.85,"total_display":"1,631,905.85","total_whole":"1,631,906","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-13","scope":"insider"},{"id":4437704,"accession":"0001213900-21-003298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-003298","line_url":"/filing/0001213900-21-003298#line-1","is_derivative":false,"issuer_cik":"0001568678","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001568678","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":51000.0,"total_display":"51,000.00","total_whole":"51,000","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-25","filed_date":"2021-01-20","scope":"insider"},{"id":9272747,"accession":"0001213900-19-021556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-021556","line_url":"/filing/0001213900-19-021556","is_derivative":false,"issuer_cik":"0001733413","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001733413","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-25","filed_date":"2019-10-30","scope":"insider","n_lines":2},{"id":8570412,"accession":"0001213900-19-021417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-021417","line_url":"/filing/0001213900-19-021417#line-1","is_derivative":false,"issuer_cik":"0001568678","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001568678","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-25","filed_date":"2019-10-29","scope":"insider"},{"id":5195057,"accession":"0000914190-13-000751","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000914190-13-000751","line_url":"/filing/0000914190-13-000751#line-3","is_derivative":false,"issuer_cik":"0001195116","issuer_name":"Arno Therapeutics, Inc","issuer_ticker":"ARNI","issuer_name_source":null,"issuer_url":"/issuer/0001195116","owner_cik":"0001568678","owner_name":"Mattes Glenn R.","owner_display_name":"Mattes Glenn R.","owner_url":"/insider/0001568678","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20833.0,"shares_display":"20,833","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":77203.0,"shares_owned_after_display":"77,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-10-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001733413","name":"TFF Pharmaceuticals, Inc.","url":"/issuer/0001733413","role":"Director, Officer (President and CEO)","n_filings":9,"first_seen":"2019-10-29","last_seen":"2022-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001195116","name":"Arno Therapeutics, Inc","url":"/issuer/0001195116","role":"Director, Officer (President & CEO)","n_filings":1,"first_seen":"2013-10-31","last_seen":"2013-10-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001568678","retrieved_at":"2026-08-23T02:44:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}